WASHINGTON — Ozempic, the blockbuster GLP-1 ... U.S. Food and Drug Administration to reduce certain risks associated with chronic kidney disease, drugmaker Novo Nordisk said Tuesday.

Share on Pinterest The FDA approved Ozempic to help lower chronic kidney disease-related risks in people with type 2 diabetes. urbazon/Getty Images The Food and Drug Administration (FDA ...

semaglutide — the active ingredient in Ozempic and Wegovy — may significantly improve kidney function in people with diabetes who have chronic kidney disease. New research results presented ...

The European Medicines Agency’s backing comes after a trial earlier this year showed that Ozempic slows the progression of chronic kidney disease and cuts the risk of kidney failure, heart ...

The post FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients appeared first on East Idaho ...

(CNN) — Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated ...

has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease, drugmaker Novo Nordisk said Tuesday. (CNN) — Ozempic ...